These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23058017)

  • 1. Dose-dependent clinical and immunological efficacy of sublingual immunotherapy with mite monomeric allergoid.
    Di Gioacchino M; Cavallucci E; Ballone E; Cervone M; Di Rocco P; Piunti E; Filardo GS; Turi MC; Mangifesta R; Quecchia C; Mistrello G; Braga M; Petrarca C
    Int J Immunopathol Pharmacol; 2012; 25(3):671-9. PubMed ID: 23058017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production.
    Cosmi L; Santarlasci V; Angeli R; Liotta F; Maggi L; Frosali F; Rossi O; Falagiani P; Riva G; Romagnani S; Annunziato F; Maggi E
    Clin Exp Allergy; 2006 Mar; 36(3):261-72. PubMed ID: 16499636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis.
    Bergmann KC; Demoly P; Worm M; Fokkens WJ; Carrillo T; Tabar AI; Nguyen H; Montagut A; Zeldin RK
    J Allergy Clin Immunol; 2014 Jun; 133(6):1608-14.e6. PubMed ID: 24388010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety, tolerability and efficacy of sublingual allergoid immunotherapy with a 4-day shortened build-up phase.
    Giordano T; Quarta C; Bruno ME; Falagiani P; Riva G
    Eur Ann Allergy Clin Immunol; 2006 Nov; 38(9):310-2. PubMed ID: 17191751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. House dust mite sublingual immunotherapy: a double-blind, placebo-controlled study in elderly patients with allergic rhinitis.
    Bozek A; Ignasiak B; Filipowska B; Jarzab J
    Clin Exp Allergy; 2013 Feb; 43(2):242-8. PubMed ID: 23331565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Observation on the effect of the dust mite sublingual immunotherapy for allergic rhinitis].
    Du X; Shu C; Xu G; Ma M; Song H
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Apr; 26(8):372-3. PubMed ID: 22730824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized double-blind controlled study with sublingual carbamylated allergoid immunotherapy in mild rhinitis due to mites.
    Passalacqua G; Pasquali M; Ariano R; Lombardi C; Giardini A; Baiardini I; Majani G; Falagiani P; Bruno M; Canonica GW
    Allergy; 2006 Jul; 61(7):849-54. PubMed ID: 16792583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, 5-arm dose finding study with a mite allergoid SCIT in allergic rhinoconjunctivitis patients.
    Pfaar O; Nell MJ; Boot JD; Versteeg SA; van Ree R; Roger A; Riechelmann H; Sperl A; Oude Elberink JN; Diamant Z; Bachert C
    Allergy; 2016 Jul; 71(7):967-76. PubMed ID: 26864207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of sublingual immunotherapy with grass monomeric allergoid: comparison between two different treatment regimens.
    Quercia O; Bruno ME; Compalati E; Falagiani P; Mistrello G; Stefanini GF
    Eur Ann Allergy Clin Immunol; 2011 Dec; 43(6):176-83. PubMed ID: 22360134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of high-dose sublingual immunotherapy in children allergic to house dust mites in real-life clinical practice.
    Ferrés J; Justicia JL; García MP; Muñoz-Tudurí M; Alvà V
    Allergol Immunopathol (Madr); 2011; 39(3):122-7. PubMed ID: 20570032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sublingual immunotherapy with house dust extract for house dust-mite allergic rhinitis in children.
    Yonekura S; Okamoto Y; Sakurai D; Horiguchi S; Hanazawa T; Nakano A; Kudou F; Nakamaru Y; Honda K; Hoshioka A; Shimojo N; Kohno Y
    Allergol Int; 2010 Dec; 59(4):381-8. PubMed ID: 20864799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of IgE neosensitization in house dust mite allergic patients following sublingual immunotherapy.
    Baron-Bodo V; Batard T; Nguyen H; Fréreux M; Horiot S; Harwanegg C; Bergmann KC; de Beaumont O; Moingeon P
    Clin Exp Allergy; 2012 Oct; 42(10):1510-8. PubMed ID: 22994348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic/rhinitis children sensitized to house dust mite: an open randomized controlled trial.
    Eifan AO; Akkoc T; Yildiz A; Keles S; Ozdemir C; Bahceciler NN; Barlan IB
    Clin Exp Allergy; 2010 Jun; 40(6):922-32. PubMed ID: 20100188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of the efficacy of specific immunotherapy with house-dust mite extracts in adults with allergic rhinitis and/or asthma].
    Polzehl D; Keck T; Riechelmann H
    Laryngorhinootologie; 2003 Apr; 82(4):272-80. PubMed ID: 12717603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of sublingual immunotherapy in Asian children.
    Park IH; Hong SM; Lee HM
    Int J Pediatr Otorhinolaryngol; 2012 Dec; 76(12):1761-6. PubMed ID: 22959336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of sublingual immunotherapy with house dust mite extract in polyallergen sensitized patients with allergic rhinitis.
    Lee JE; Choi YS; Kim MS; Han DH; Rhee CS; Lee CH; Kim DY
    Ann Allergy Asthma Immunol; 2011 Jul; 107(1):79-84. PubMed ID: 21704889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term efficacy of sublingual immunotherapy in patients with perennial rhinitis.
    Tahamiler R; Saritzali G; Canakcioglu S
    Laryngoscope; 2007 Jun; 117(6):965-9. PubMed ID: 17545861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of a once-daily sublingual immunotherapy without escalation regimen in house dust mite-induced allergic rhinitis.
    Mun SJ; Shin JM; Han DH; Kim JW; Kim DY; Lee CH; Min YG; Rhee CS
    Int Forum Allergy Rhinol; 2013 Mar; 3(3):177-83. PubMed ID: 23044892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. House dust mite sublingual immunotherapy: results of a US trial.
    Bush RK; Swenson C; Fahlberg B; Evans MD; Esch R; Morris M; Busse WW
    J Allergy Clin Immunol; 2011 Apr; 127(4):974-81.e1-7. PubMed ID: 21333346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-lasting effects of sublingual immunotherapy for house dust mites in allergic rhinitis with bronchial hyperreactivity: A long-term (13-year) retrospective study in real life.
    Marogna M; Bruno M; Massolo A; Falagiani P
    Int Arch Allergy Immunol; 2007; 142(1):70-8. PubMed ID: 17016060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.